<code id='D2CC2C168F'></code><style id='D2CC2C168F'></style>
    • <acronym id='D2CC2C168F'></acronym>
      <center id='D2CC2C168F'><center id='D2CC2C168F'><tfoot id='D2CC2C168F'></tfoot></center><abbr id='D2CC2C168F'><dir id='D2CC2C168F'><tfoot id='D2CC2C168F'></tfoot><noframes id='D2CC2C168F'>

    • <optgroup id='D2CC2C168F'><strike id='D2CC2C168F'><sup id='D2CC2C168F'></sup></strike><code id='D2CC2C168F'></code></optgroup>
        1. <b id='D2CC2C168F'><label id='D2CC2C168F'><select id='D2CC2C168F'><dt id='D2CC2C168F'><span id='D2CC2C168F'></span></dt></select></label></b><u id='D2CC2C168F'></u>
          <i id='D2CC2C168F'><strike id='D2CC2C168F'><tt id='D2CC2C168F'><pre id='D2CC2C168F'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:6
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In
          Previous article: Surgery pushed Ben Carson to fame
          Next article: Alkermes shareholders re

          comprehensive

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Cosmetics set for new safety regulation. Why the industry is on board
          Cosmetics set for new safety regulation. Why the industry is on board

          AlbertoPellaschiar/APWASHINGTON—ForthosealreadyfelledbyfumesfromtheBrazilianBlowout,itmightbesmallco

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          Cano Health’s bankruptcy is a warning for Medicare Advantage

          AdobePrivateMedicarejustisn’tthegoldmineitoncewas.Caseinpoint:CanoHealth,acompanyoncevaluedat$4.4bil